Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institutionYonatan Kok,Jenny Nicolopoulos,Con DolianitisAustralasian Journal of Dermatology（2021）引用 14|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
